[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

GBIC: Ready to make monumental leaps and bounds



Did you turn a 730% gain on your investment in 16 Days?
If you bought Laforza Automobiles, Inc. (OTC PK: LFZA) you would have realized a 730% GAIN in less than 16 days!!! LFZA surged from 11 cents to 84 cents!

Gulf Biomedical Corporation (OTC PK: GBIC) is our latest Hot Stock Pick!!! Gulf Biomedical Corporation is a diversified company focused on generating residual revenue in high growth industries such as herbal products and oil and gas production. The Companies herbal division targets four high revenue generating segments, Erectile Dysfunction, Hair Restoration, Anti-Depression and Weight Loss. These products are available in the US and overseas. Management has now expanded business operations and acquired four oil wells within Texas which are anticipated to generate very strong revenues.

Don’t Miss Out on the next BIG move!!! Look for large volume increases, followed by a continued sharp rise in share price.


Gulf Biomedical Corporation
For More Information visit: www.gulfbiomedicalgroup.com

Gulf Biomedical Corporation has 4 major fundamental investor facts speculative investors should take notice of:

  • Small Float Could Create Rapid Rise in Stock: Gulf Biomedical Corporations stock is structured for strong upward momentum going forward. Management anticipating record revenue growth.
  • GBIC Expands into High Growth Oil and Gas Industry: Gulf Biomedical announces acquisition of four oil wells located in Luling Caldwell County, Texas. Anticipates strong residual revenue during life of wells. GBIC retains Triton American Energy (OTC PK: TRAE) to manage field operations.
  • Management Anticipates Record Residual Revenue Growth in 2007: Record revenue growth anticipated due to four oil wells scheduled for production in first quarter 2007. Additional growth to be generated from continued national sales of herbal product line including Hair Restoration, Erectile Dysfunction, Weight Loss and Anti-Depression pills. 91 million American currently take herbal pills.
  • GBIC Launches Global Distribution Program of Herbal Products: Global Distribution Program now available for companies and individuals. Program created for increased order demand and brand awareness.

Gulf Biomedical Corporation (OTC PK: GBIC) is a diversified company focused on generating residual revenue in high growth industries such as herbal products and oil and gas production. The Company herbal division targets four high revenue generating segments, Erectile Dysfunction, Hair Restoration, Anti-Depression and Weight Loss. All products are created to be safe, reliable and backed by quality customer service. Gulf Biomedical oil and gas division targets the small to moderate operations (usually 1-50 well projects). These wells can be very valuable in terms of revenue but require more hands-on attention then major producers are willing to give.

Gulf Biomedical Acquires Four Oil Wells:
GBIC completes acquisition of four oil wells known as the Southern Pacific Company Lease. These wells are located in the Luling Caldwell County, Texas and are anticipated to generate long-term residual revenue. Income from well operations will flow directly into Gulf Biomedicals earnings.

Gulf Biomedical in Final Negotiations to Acquire Two Additional Oil Wells:
Wells are listed as the Sadie Epstein Lease. Under the terms of agreement, Gulf Biomedical will retain 50 percent interest of the wells and utilize Triton American Energy (OTC PK: TRAE) to manage all field operations.

  1. GBIC Acquires 4 Oil Wells. Strong Revenue Anticipated from Wells by First Quarter 2007. Management in Final Negotiations to Acquire 2 Additional Oil Wells.
  2. Stock structured with Small Float. Small Float Could Create Rapid Rise in Stock Price. Stock Symbol LFZA Already Experienced 730% Rise in 16 Days.
  3. GBIC Launches Global Distributor Program of Herbal Products. Program Designed to Spark Record Product Orders and Brand Awareness.
  4. 91 Million American Currently Take Herbal Products. Increased Drug Fears and FDA Warnings Creating Surge in Demand of Safe Alternative Herbal Products.

Take advantage of current trading levels. This is a ground floor opportunity you can’t afford to miss. At current price levels, a little bit of movement will go a long way.

Look for heavy volume and significant price increases in the short term. The price of GBIC is currently trading at $0.11. This is an inexpensive stock by anyone’s standards. Don’t Miss Out!!!

Symbol: OTC PK: GBIC        Current Price: 11 cents

IR Contact: Investor Relations 973-351-3868

Rothrock International Limited based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by Rothrock International Limited to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Rothrock International Limited is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Rothrock International Limited has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. Rothrock International Limited has been compensated by third party shareholders or with cash from the company on behalf of GBIC. Rothrock International Limited has been compensated five hundred dollars on behalf of GBIC for dissemination of this opinion and other professional services.

Rothrock International Limited ‘s affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Rothrock International Limited will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies` annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Rothrock International Limited undertakes no obligation to update such statements.




Rothrock International Limited · 166 North Front St., Ste. 252 · Belize City, Belize Central America